{
    "Trade/Device Name(s)": [
        "ADVIA Centaur Cortisol (COR) Assay"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Inc.",
    "510(k) Number": "K142723",
    "Predicate Device Reference 510(k) Number(s)": [
        "K962559"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JFT"
    ],
    "Summary Letter Date": "February 18, 2015",
    "Summary Letter Received Date": "February 19, 2015",
    "Submission Date": "March 25, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.1250"
    ],
    "Regulation Name(s)": [
        "Cortisol (hydrocortisone and hydroxycorticosterone) test system"
    ],
    "Analyte Class(es)": [
        "endocrine",
        "chemistry"
    ],
    "Analyte(s)": [
        "Cortisol"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ADVIA Centaur XP system",
        "ADVIA Centaur Family of analyzers"
    ],
    "Method(s)/Technology(ies)": [
        "Competitive immunoassay",
        "Direct chemiluminescent"
    ],
    "Methodologies": [
        "Immunoassay",
        "Chemiluminescence"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Calibrator",
        "Diluent",
        "Curve Material",
        "Buffer"
    ],
    "Document Summary": "FDA 510(k) summary for ADVIA Centaur Cortisol (COR) Assay using competitive direct chemiluminescent immunoassay for cortisol quantitation on ADVIA Centaur XP system",
    "Indications for Use Summary": "For in vitro diagnostic use in the quantitative determination of cortisol in serum or urine using the ADVIA Centaur XP system; measurements are used in the diagnosis and treatment of disorders of the adrenal gland.",
    "fda_folder": "Clinical Chemistry"
}